Skip to main content

DCVMN Members committed to boost global access to high-quality vaccines

Geneva 10h August 2015 – DCVMN Member companies have reached an understanding to cooperate in an effort to increase and maintain the number of WHO prequalified vaccines available for international procurement, and to achieve a more sustainable and secure supply of priority vaccines, as identified by global health agencies such as WHO, UNICEF and Gavi, the Vaccine Alliance. All corporate members are invited to join the effort. The agreements highlight the principles of Global Access to ensure the development, manufacture and delivery of vaccines available and accessible in terms of quality, quantity and affordability to people in need in the developing world. For that purpose DCVNM members committed to Global Access to vaccines through a Memorandum of Understanding – between DCVMN and Member Companies – that provides a mechanism through which they can work together at both a strategic level and a specific project level. DCVMN Member Companies share the common goal of protecting people from infectious diseases, by accelerating access to affordable high-quality vaccines: “Our focus is twofold: high-quality vaccines for all people and dialogue with stakeholders, to assist manufacturers in getting the knowledge, tools and skills required to attain and maintain WHO prequalification status giving access to priority vaccines”, emphasized Mahendra Suhardono, President of the Network. DCVMN Member companies[[In alphabetical order]] that committed to Global Access to Vaccines through a signed MOU to date include: Arabio Co. Beijing Minhai Biotechnology Co. Ltd Bharat Biotech International Ltd Bio Farma PT Biological E Ltd Bio-Manguinhos Fiocruz BioNet-Asia Co. Ltd Biovac Institute BravoVax Co. Ltd Butantan Institute Cadila Biopharmaceuticals Changchun BCHT Biotechnology Co. China National Biotec Group Company Ltd EuBiologics Co. Ltd Finlay Instituto Fundacao Ataulpho De Paiva Incepta Vaccine Ltd Indian Immunologicals Ltd Laboratorios de Biologicos y Reactivos de Mexico S.A de C.V LG Life Sciences Liaoning ChengDa Biotechnology Co. Ltd (CDBIO) Medigen Vaccinology Corporation Panacea Biotec Ltd Pasteur Institute of Iran Polyvac Razi Vacccine & Serum Research Institute Serum Institute of India Ltd (Poonawalla Group) Sinergium Biotech Sinovac Sk Chemicals Thai Red Cross Society- Queen Saovabha Memorial Institute The National Insitute of Infectious Diseases and Vaccinology (NIIDV) The Institute of Medical Biology, Chinese Academy of Medical Sciences (IMBCAMS) Tiantian Bio Vabiotech Vacsera VINS Bioproducts Ltd Walvax Biotechnology Co. Ltd Xiamen Innovax Biotech Co. Ltd

Attached documents